IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — ACLX

Balance Sheet

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022
Cash & Equivalents79.0162.3480.86161.85100.03154.57126.12303.67274.8956.76164.54127.16
Short-term Investments382.38390.77462.40412.41416.66419.35313.60202.82258.70224.02142.4583.77
Total Current Assets472.08463.90554.15587.30530.20588.73491.46558.07571.37290.31325.08224.39
Property, Plant & Equipment43.0844.4745.5747.5046.2844.9337.7822.2914.4210.039.669.75
Total Non-current Assets*183.84155.1993.93177.61204.10190.96122.7665.4651.5847.0249.5822.60
Total Assets655.92619.09648.08764.91734.31779.70614.22623.53622.94337.33374.66246.98
Accounts Payable4.202.084.375.994.873.107.195.694.532.967.561.87
Total Current Liabilities118.39121.85112.46137.0288.29107.90173.15156.11166.0644.7823.7314.43
Total Non-current Liabilities*96.75105.01118.72144.87158.85175.22174.94173.75153.1756.2727.324.62
Total Liabilities215.14226.86231.18281.89247.14283.12348.09329.86319.23101.0451.0419.05
Retained Earnings(667.65)(611.87)(559.10)(449.75)(423.88)(396.68)(409.32)(369.99)(346.13)(279.80)(186.92)(156.15)
Total Stockholder Equity440.78392.22416.91483.02487.16496.57266.13293.67303.72236.28323.62227.94

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Revenue1.654.957.558.1315.2726.0327.3839.2663.1514.9614.3017.91--0.000.000.00
Research & Development34.1035.0937.6350.8044.6539.1740.9532.3228.7843.8128.3332.9325.9483.4722.0818.06
Selling, General & Admin31.2431.6428.6526.2323.7720.4721.4222.7519.3716.0115.5415.4414.0610.409.218.03
Total Operating Expenses65.3466.7266.2877.0368.4259.6562.3855.0748.1559.8243.8648.3740.0093.8831.2926.09
Operating Income(63.68)(61.78)(58.73)(68.90)(53.15)(33.62)(34.99)(15.81)15.00(44.86)(29.56)(30.46)(40.00)(93.87)(31.29)(26.09)
Interest Expense--------------------------0.60----
Pretax Income(58.07)(55.78)(52.74)(62.27)(45.58)(25.64)(26.86)(7.20)20.47(39.34)(24.14)(27.01)--------
Tax Provision0.040.000.030.001.510.220.340.000.62(0.01)(0.28)0.330.00------
Net Income(58.11)(55.78)(52.77)(62.27)(47.08)(25.87)(27.20)(7.20)19.84(39.34)(23.85)(27.34)(38.99)(92.87)(30.77)(26.04)
Basic EPS(1.01)(0.99)(0.94)(1.13)(0.87)(0.48)(0.51)(0.14)0.42(0.81)(0.50)(0.58)(0.76)(2.12)(0.84)(1.25)
Diluted EPS(1.01)(0.99)(0.94)(1.13)(0.87)(0.48)(0.51)(0.14)0.42(0.81)(0.50)(0.58)(0.76)(2.12)(0.84)(1.25)

Cash Flow Statement

(in millions USD)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(58.17)(49.21)(39.73)(63.14)(46.03)30.72(36.25)(31.91)58.25(10.10)(22.61)182.04(27.52)(16.65)(22.55)(32.59)
Capital Expenditures0.760.300.490.781.502.293.216.435.297.937.230.981.280.390.150.47
Free Cash Flow*(58.94)(49.50)(40.22)(63.92)(47.53)28.43(39.46)(38.34)52.96(18.03)(29.84)181.06(28.80)(17.03)(22.70)(33.05)
Investing Cash Flow57.80(20.03)10.7437.78(4.12)35.76(7.87)(206.81)21.02(160.03)51.27(66.77)33.62(61.07)(0.18)(10.64)
Financing Cash Flow1.6386.1010.260.54(6.02)(4.66)(10.43)(2.98)188.59(4.99)0.1295.451.31(9.71)121.46139.56

* Derived from reported values